Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 USD | -5.54% | -10.77% | -64.37% |
28/05 | RBC Halves Price Target on Verastem to $16 From $32, Maintains Outperform Rating, Speculative Risk Qualifier | MT |
24/05 | Top Midday Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.37% | 73.44M | |
+16.13% | 122B | |
+19.65% | 113B | |
+19.21% | 26.49B | |
-23.84% | 19.4B | |
-18.05% | 16.24B | |
-45.95% | 15.15B | |
-19.28% | 15.4B | |
+63.81% | 14.93B | |
+1.94% | 13.52B |
- Stock Market
- Equities
- VSTM Stock
- News Verastem, Inc.
- Verastem Partners With GenFleet Therapeutics to Advance Oncology Discovery Programs